References
- KamravaMTsangKYMadanRAKaushalAColemanCNGulleyJLong-term survival and PSA control with radiation and immunotherapy for node positive prostate cancerClin Dev Immunol2009200936391420224813
- TanabeKSuzukiTTokumotoNYamamotoHYoshidaKOhdanHCombination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysisWorld J Surg Oncol201084020482840
- ChaoMPAlizadehAATangCAnti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphomaCell201014269971320813259
- BlierPWardHETremblayPLabergeLHébertCBergeronRCombination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized studyAm J Psychiatry201016728128820008946
- GranichRCrowleySVitoriaMHighly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and updateCurr Opin HIV AIDS2010529830420543604
- FrokjaerSOtzenDEProtein drugs stability: a formulation challengeNat Rev Drug Discov2005429830615803194
- BartusRTTracyMAEmerichDFZaleSESustained delivery of proteins for novel therapeutic productsScience1988281116111629735031
- PutneySDBurkePAImproving protein therapeutics with sustained-release formulationsNat Biotechnol1998161531579487521
- ClelandJLJohnsonOLPutneySJonesAJSRecombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation developmentAdv Drug Deliv Rev199728718410837565
- WuFJinTPolymer-based sustained-release dosage forms for protein drugs, challenges, and recent advancesAAPS PharmSci Tech2009912181229
- ZhangXMcAuleyKBGossenMFATowards prediction of release profiles of antibiotics from coated poly(DL-lactide) cylindersJ Control Release199534175179
- YollesSLeafeTDWoodandJHMeyerFJLong acting delivery systems for narcotic antagonists II: release rates of naltrexone from poly(lactic acid) compositesJ Pharm Sci1975643483491127596
- CaoXShoichetMSDelivering neuroactive molecules from biodegradable microspheres for application in central nervous system disordersBiomaterials19992032933910048405
- BurtHMZhangXToleikisPEmbreeLHunterWLDevelopment of copolymers of poly(D,L-lactide) and methoxypolyethylene glycol as micelles carriers of paclitaxelColloids Surfaces199916161171
- LeeJChoECChoKIncorporation and release behavior of hydrophobic drug in functionalized poly(D,L-lactide)-blockpoly(ethylene oxide) micellesJ Control Release20049432333514744484
- AgrawalSKSanabria-DelongNCoburnJMTewGNBhatiaSRNovel drug release profiles from micellar solutions of PLA-PEG-PLA triblock copolymersJ Control Release2006112647116507325
- YamamotoYNagasakiYKatoYSugiyamaYKataokaKLong-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface chargeJ Control Release200177273811689257
- CalicetiPSalmasoSElvassoreNBertuccoAEffective protein release from PEG/PLA nano-particles produced by compressed gas anti-solvent precipitation techniquesJ Control Release20049419520514684283
- ChengJTeplyBASherifiIFormulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug deliveryBiomaterials20072886987617055572
- WenJKimGJALeongKWPoly(D,L-lactide-co-ethyl ethylene phosphate)s as new drug carriersJ Control Release200392394814499184
- PanJZhaoMLiuYWangBMiLYangLDevelopment of a new poly(ethylene glycol)-graft-poly(D,L-lactic acid) as potential drug carriersJ Biomed Mater Res A20098916016718431784
- PanJWangYQinSZhangBLuoYGrafting reaction of poly(D,L) lactic acid with maleic anhydride and hexanediamine to introduce more reactive groups in its bulkJ Biomed Mater Res B Appl Biomater20057447648015889445
- KwonGNaitoMYokoyamaMOkanoTSakuraiYKataokaKMicelles based on AB block copolymers of poly(ethylene oxide) and poly(β-benzyl L-aspartate)Langmuir19939945949
- GrefRLückMQuellecP‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): Influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorptionColloids Surf B Biointerfaces20001830131310915952
- JelvehgariMZakeri-MilaniPSiahi-ShadbadMRDevelopment of pH-sensitive insulin nanoparticles using Eudragit L100–155 and chitosan with different molecular weightsAAPS Pharm Sci Tech201011312371242
- AvadiMRSadeghiAMMohammadpourNPreparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation methodNanomedicine20106586319447202
- SarmentoBRibeiroAVeigaFFerreiraDDevelopment and characterization of new insulin containing polysaccharide nanoparticlesColloids Surf B Biointerfaces20065319320217049214
- SarmentoBRibeiroAVeigaFSampaioPNeufeldRFerreiraDAlginate/chitosan nanoparticles are effective for oral insulin deliveryPharm Res2007242198220617577641
- ChalasaniKKRussell-JonesGJYandrapuSKDiwanPVJainSKA novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulinJ Control Release200711742142917239471
- SunSLiangNPiaoHYamamotoHKawashimaYCuiFInsulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluationJ Microencapsul20102747147820113168
- FanYFWangYNFanYGMaJBPreparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorptionInt J Pharm200632415816716814967
- Zeta Potential-An Introduction in 30 Minutes. Technical Note Available from: http://www.malvern.com/malvern/kbase.nsf/allbyno/KB000734/$file/MRK654-01An Introduction to Zeta Potential v3.pdfAccessed May 4, 2011
- MillerLHPowersKGFinertyJVanderbergJPDifference in surface charge between host cells and malarial parasitesJ Parasitol1973599259274200702
- SarmentoBRibeiroAVeigaFFerreiraDDevelopment and characterization of new insulin containing polysaccharide nanoparticlesColloids Surf B Biointerfaces20065319320217049214
- JavadzadehYAhadiFDavaranSMohammadiGSabzevariAAdibkiaKPreparation and physicochemical characterization of naproxen-PLGA nanoparticlesColloids Surf B Biointerfaces201081249850220719477
- RodriguesMRLanzariniCMRicci-JuniorEPreparation, in vitro characterization and in vivo release of naproxen loaded in poly-caprolactone nanoparticlesPharm Dev Technol2011161122120001271
- PugliaCBoninaFRizzaLEvaluation of percutaneous absorption of naproxen from different liposomal formulationsJ Pharm Sci2010992819282920039387
- OuyangLMaLJiangBLiYHeDGuoLSynthesis of novel dendrimers having aspartate grafts and their ability to enhance the aqueous solubility of model drugsEur J Med Chem2010452705271120171762